Denying effective antiretroviral drugs to HIV-positive pregnant women--the national government's flawed decision.
Lurie
M
M
Lurie
P
P
IJsselmuiden
C
C
Gray
G
G
D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D006679:HIV Seropositivity / Q000191:economics / Q000635:transmission*; D006291:Health Policy; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D016896:Treatment Outcome; D015215:Zidovudine / Q000191:economics / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D015215:Zidovudine